14 markets on 3 continents.
Asia, Africa and South America. Frontier markets with their own rules, buyers and clocks, read and run one at a time.
KazakhstanUzbekistanAzerbaijan
KenyaUgandaTanzaniaRwanda
NigeriaGhanaSenegalFrancophone West and Central Africa
SudanLibya
Iraq
Peru
Six regions. Six strategies.
Pick a region to see how we think about entering it.
One dossier, five markets.
With Kazakhstan as EAEU reference state, one registration can be extended to Russia, Belarus, Armenia and Kyrgyzstan. Kazakhstan's national route closes on 31 Dec 2027, so the order of filing matters now.
- Kazakhstan's national route closes on 31 Dec 2027
- Uzbekistan cut review times to 60–120 days in Nov 2025
A good dossier now travels.
Seven East African regulators share assessment work and the CTD format is mandatory. Done right once, a dossier opens the region.
- 7 regulators share assessment work
- CTD format mandatory across the region
Import-led, centrally bought.
Much of the volume runs through central state buyers. Winning here is about registration and price, not presence.
- Central state buyers, such as SEN-PNA in Senegal
- 2 WHO-prequalified local makers in Nigeria
Supply is being rebuilt.
National buyers are rebuilding supply and need reliable makers. Early, compliant suppliers earn the position.
- 13 factories back in production in Sudan
- Libya's first national import tender in a decade (2024)
One buyer decides.
A single state importer sets the volume. The strategy is to be registered, priced and ready when its lists open.
- Single state importer: Kimadia
- More than 40% of demand made locally
Price-led, centrally bought.
A central state buyer and a price-led market, where Indian generics already lead at about 14.5% of supply.
- Central state buyer: CENARES
- Regulator: DIGEMID
What we know about each one.
Our view of each market in two facts. Kazakhstan is shown in full; every other market file is available on request.
Kazakhstan
- USD 2.5bn medicines market (2025)
- 85% of value imported
Uzbekistan
- 38.2m people (2026)
- Registration review 60–120 days since Nov 2025
Azerbaijan
- Pharmaceutical imports up 4.6% in H1 2025
Kenya
- State buyer: KEMSA
- Regulator: Pharmacy and Poisons Board, 90-day verification route
Uganda
- State buyer: National Medical Stores
- 25 licensed manufacturing sites, 13 producing
Tanzania
- State buyer: MSD, about USD 491m a year
- Regulator: TMDA, generics approved in about 61 days (2022)
Francophone West and Central Africa
- Dossiers in French, regional regulators
- Côte d'Ivoire market about EUR 537m
Sudan
- 13 factories back in production
- National fund reports availability above 70%
Libya
- State buyer: Medical Supply Organization
- First national import tender in a decade (2024)
Iraq
- Single state importer: Kimadia
- More than 40% of demand made locally
The rules are changing. Early movers win.
The African Medicines Agency became operational in October 2025. East Africa already shares assessments across 7 regulators.
National registrations not aligned to EAEU rules are being annulled in several member states. Kazakhstan's national route closes on 31 Dec 2027.
Uzbekistan cut registration review times to 60–120 days in Nov 2025. Early filers get the head start.
Ask for a market file.
Tell us which market interests you. We will show you what is open there. We reply within one working day.
- UK · WhatsApp
- +44 7466 253544
- Kazakhstan · WhatsApp
- +7 708 692 2409
- Pakistan
- +92 325 4307967
- [email protected]